Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report.
Salmanton-García J, Marchesi F, Glenthøj A, Bilgin YM, van Praet J, Dávila-Valls J, Martín-Pérez S, Labrador J, van Doesum J, Falces-Romero I, Farina F, Schönlein M, Chanut M, Petzer V, Espigado I, Dargenio M, Aujayeb A, Sili U, Serrano L, Pinczés LI, de Jonge N, Soto-Silva A, Buquicchio C, Prezioso L, Marchetti M, Meers S, Busca A, Corradini P, Hoenigl M, Koehler P, Rahimli L, Çolak GM, Arellano E, Wolf D, Gräfe S, Ammatuna E, Berg Venemyr C, Cornely OA, Pagano L.
Salmanton-García J, et al. Among authors: buquicchio c.
Hemasphere. 2022 Oct 25;6(11):e789. doi: 10.1097/HS9.0000000000000789. eCollection 2022 Nov.
Hemasphere. 2022.
PMID: 36310756
Free PMC article.
No abstract available.